OASYS NOW, a Dutch startup founded in 2021, is pioneering the realm of Health Data Intelligence by offering innovative solutions that allow health data holders to capitalize on their existing clinical data infrastructure. Emphasizing a Privacy-by-Design philosophy, the company ensures that sensitive information is processed without any data harmonization or offsite data transfer, effectively addressing a critical pain point in the healthcare and life sciences industries.
Their portfolio includes De-ID, an on-premise pseudonymization tool that meets EHDS compliance standards; AI Readiness, a foundation for scalable AI applications; and ELaiGIBLE, a solution for accelerating patient recruitment in clinical trials. Garnering recognition from notable lists like Forbes 30 Under 30 (Europe) and SLUSH 100, OASYS NOW stands out in the competitive sectors of AI, Biotechnology, and Cyber Security.
Recently, the company secured a €1.00M Early VC investment from investors such as Cherry Ventures and General Catalyst, signaling strong market confidence and growth potential.